Happy International Women in Engineering Day!

To celebrate International Women in Engineering day (23 June 2020), Shelston IP would like to highlight our outstanding female patent attorneys and patent engineers qualified in this field.   With 30 years of experience in the patent profession, Caroline Bommer is the female engineer that we aspire to be. She provides a wonderful example of

How to use post-filing experimental data to help establish sufficiency and support

The Intellectual Property Laws Amendment (Raising the Bar) Act 2012 was introduced in Australia with the intention of aligning Australia’s written description requirements with those in the UK and Europe. Under the new Act, a specification must disclose the invention in a manner which is clear enough and complete enough for the invention to be

NAB’s reputation takes it over the bridge

In the Registrar’s decision of National Australia Bank Limited [2020] ATMO 41 (19 March 2020), National Australia Bank (“NAB”) have successfully relied upon the their significant reputation in Australia to overcome citations of prior rights and secure acceptance of the composite logo mark (“NAB Logo mark”) shown below.  The Registrar followed the previous decision of

Shelston IP – A Tier One Firm in Both Patents and Trade Marks

The international IP journal Managing Intellectual Property (MIP) conducts a worldwide survey of IP practitioners each year as a key benchmark for the industry.  We are delighted to announce that Shelston IP has, for 2020, been ranked by MIP as a Tier 1 firm for patent prosecution in Australia. This ranking reflects the calibre of our

IP Australia extends period for requesting extensions of time for deadlines which cannot be met due to COVID-19

Initially, in April 2020, IP Australia announced that free extensions of time of up to three months could be requested until 31 May 2020 when a deadline could not be met due to the effects of COVID-19.  We are pleased to report that this period has now been extended until 30 June 2020.  Depending on

Patenting proteins: an Australian perspective

Biological molecules, including polypeptides and, in some cases, nucleic acids, can be patented under Australian law.  The level of disclosure that is required to support and enable a claim to a polypeptide will depend on several factors, including:   i.    the identity of the person skilled in the art; ii.   the information disclosed in

Page 3 of 6212345...102030...Last »